(VIANEWS) – Monolithic Power Systems (MPWR), Hexcel Corporation (HXL), Amphastar Pharmaceuticals (AMPH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Monolithic Power Systems (MPWR)
15.4% sales growth and 21.09% return on equity
Monolithic Power Systems, Inc. engages in the design, development, marketing, and sale of semiconductor-based power electronics solutions for the storage and computing, automotive, enterprise data, consumer, communications, and industrial markets. The company provides direct current (DC) to DC integrated circuits (ICs) that are used to convert and control voltages of various electronic systems, such as cloud-based CPU servers, server artificial intelligence applications, storage applications, commercial notebooks, digital cockpit, power sources, home appliances, 4G and 5G infrastructure, and satellite communications applications. It offers lighting control ICs for backlighting that are used in systems, which provide the light source for LCD panels in computers and notebooks, monitors, car navigation systems, and televisions, as well as for general illumination products. The company sells its products through third-party distributors, value-added resellers, directly to original equipment manufacturers, original design manufacturers, electronic manufacturing service providers, and other end customers. It serves China, Taiwan, South Korea, Europe, Japan, Southeast Asia, the United States, and internationally. Monolithic Power Systems, Inc. was incorporated in 1997 and is headquartered in Kirkland, Washington.
Earnings Per Share
As for profitability, Monolithic Power Systems has a trailing twelve months EPS of $8.76.
PE Ratio
Monolithic Power Systems has a trailing twelve months price to earnings ratio of 75.14. Meaning, the purchaser of the share is investing $75.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.09%.
2. Hexcel Corporation (HXL)
12.4% sales growth and 6.11% return on equity
Hexcel Corporation, together with its subsidiaries, develops, manufactures, and markets structural materials for use in commercial aerospace, space and defense, and industrial markets. It operates through two segments, Composite Materials and Engineered Products. The Composite Materials segment manufactures and markets carbon fibers, fabrics and specialty reinforcements, prepregs and other fiber-reinforced matrix materials, structural adhesives, honeycomb, molding compounds, tooling materials, polyurethane systems, and laminates that are used in military and commercial aircraft, wind turbine blades, recreational products, and other industrial applications, as well as in automotive, marine, and trains. The Engineered Products segment manufactures and markets aircraft structures and finished aircraft components, including wing to body fairings, wing panels, flight deck panels, door liners, rotorcraft blades, spars, and tip caps; and aircraft structural sub-components and semi-finished components used in rotorcraft blades, engine nacelles, and aircraft surfaces, such as flaps, wings, elevators, and fairings. The company sells its products directly through its managers, product managers, and sales personnel, as well as through independent distributors and manufacturer representatives in the Americas, Europe, the Asia Pacific, India, and Africa. Hexcel Corporation was founded in 1946 and is headquartered in Stamford, Connecticut.
Earnings Per Share
As for profitability, Hexcel Corporation has a trailing twelve months EPS of $1.16.
PE Ratio
Hexcel Corporation has a trailing twelve months price to earnings ratio of 60.12. Meaning, the purchaser of the share is investing $60.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.11%.
3. Amphastar Pharmaceuticals (AMPH)
11.6% sales growth and 25.34% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $2.91.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 14.6. Meaning, the purchaser of the share is investing $14.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.34%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 23.1% and a drop 13.9% for the next.
4. Kadant (KAI)
11.5% sales growth and 15.35% return on equity
Kadant Inc. supplies equipment and critical components worldwide. The company's Papermaking Systems segment develops, manufactures, and markets custom-engineered stock-preparation systems and equipment for the preparation of wastepaper for conversion into recycled paper and balers, as well as related equipment used in the processing of recyclable and waste materials; and fluid-handling systems and equipment used in industrial piping systems to compensate for movement, as well as to transfer fluid, power, and data. This segment also offers doctoring systems and equipment, and related consumables to enhance the operation of paper machines and other industrial processes; and filtration and cleaning systems for draining, purifying, and recycling process water, as well as cleaning fabrics, belts, and rolls in various process industries. Its Wood Processing Systems segment develops, manufactures, and markets debarkers, stranders, chippers, logging machinery, and related equipment used in the harvesting and production of lumber and oriented strand board, an engineered wood panel product used primarily in home construction. The company's Material Handling Systems segment develops, manufactures, and markets material handling equipment and systems, such as idler rolls, conveyors, vibratory screens, and flow aids to various process industries, including mining, aggregates, food processing, packaging, and pulp and paper industries. It also manufactures and sells biodegradable absorbent granules for use as carriers in agricultural, home lawn and garden, professional lawn, and turf and ornamental applications, as well as for oil and grease absorption. The company was formerly known as Thermo Fibertek Inc. and changed its name to Kadant Inc. in July 2001. Kadant Inc. was founded in 1991 and is headquartered in Westford, Massachusetts.
Earnings Per Share
As for profitability, Kadant has a trailing twelve months EPS of $9.48.
PE Ratio
Kadant has a trailing twelve months price to earnings ratio of 28.48. Meaning, the purchaser of the share is investing $28.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.35%.
5. America Movil (AMX)
11.3% sales growth and 15.9% return on equity
América Móvil, S.A.B. de C.V. provides telecommunications services in Latin America and internationally. The company offers wireless and fixed voice services, including airtime, local, domestic, and international long-distance services; and network interconnection services. It provides data services, such as data centers, data administration, and hosting services to residential and corporate clients; value-added services, including Internet access, messaging and other wireless entertainment, and corporate services; data transmission, email services, instant messaging, content streaming, and interactive applications; and wireless security services, mobile payment solutions, machine-to-machine services, mobile banking, virtual private network services, and video calls and personal communications services. In addition, the company offers residential broadband services; IT solutions to small businesses and large corporations; and cable and satellite television subscriptions. Further, it sells equipment, accessories, and computers; and offers telephone directories, wireless security, call center, advertising, media, and software development services. Additionally, the company provides video, audio, and other media content through the Internet directly from the content provider to the end user. It sells its products and services under the Telcel, Telmex Infinitum, and A1 brands through a network of retailers and service centers to retail customers; and through sales force to corporate customers. The company was incorporated in 2000 and is based in Mexico City, Mexico.
Earnings Per Share
As for profitability, America Movil has a trailing twelve months EPS of $1.49.
PE Ratio
America Movil has a trailing twelve months price to earnings ratio of 12.11. Meaning, the purchaser of the share is investing $12.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.9%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 9, 2023, the estimated forward annual dividend rate is 0.53 and the estimated forward annual dividend yield is 2.74%.
Volume
Today’s last reported volume for America Movil is 748907 which is 48.77% below its average volume of 1462060.
Moving Average
America Movil’s value is below its 50-day moving average of $18.95 and under its 200-day moving average of $18.29.
Revenue Growth
Year-on-year quarterly revenue growth declined by 2.7%, now sitting on 810.38B for the twelve trailing months.
6. Sprouts Farmers Market (SFM)
7.6% sales growth and 26.24% return on equity
Sprouts Farmers Market, Inc. offers fresh, natural, and organic food products in the United States. The company offers perishable product categories, including fresh produce, meat, seafood, deli, bakery, floral and dairy, and dairy alternatives; and non-perishable product categories, such as grocery, vitamins and supplements, bulk items, frozen foods, beer and wine, and natural health and body care. As of January 2, 2022, it operated 374 stores in 23 states. Sprouts Farmers Market, Inc. was founded in 2002 and is headquartered in Phoenix, Arizona.
Earnings Per Share
As for profitability, Sprouts Farmers Market has a trailing twelve months EPS of $2.89.
PE Ratio
Sprouts Farmers Market has a trailing twelve months price to earnings ratio of 27.19. Meaning, the purchaser of the share is investing $27.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.24%.
Sales Growth
Sprouts Farmers Market’s sales growth is 8.3% for the ongoing quarter and 7.6% for the next.
Yearly Top and Bottom Value
Sprouts Farmers Market’s stock is valued at $78.57 at 16:22 EST, below its 52-week high of $78.81 and way above its 52-week low of $32.12.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.7%, now sitting on 6.99B for the twelve trailing months.
7. Pampa Energia S.A. Pampa Energia S.A. (PAM)
6.7% sales growth and 3.12% return on equity
Pampa Energía S.A. operates as an independent energy integrated company in Argentina. The company operates through Electricity Generation, Oil and Gas, Petrochemicals, and Holding and Other Business segments. It generates electricity through thermal generation plants, thermal gas-fired thermal generation plants, and hydroelectric power generation systems, as well as through a wind farm. The company also explores for and produces oil and gas; produces petrochemicals, such as styrene, styrene butadiene rubber, and polystyrene; and operates high voltage electricity transmission network. In addition, it engages in gas transportation and advisory services activities. The company was formerly known as Pampa Holding S.A. and changed its name to Pampa Energía S.A. in September 2008. Pampa Energía S.A. was incorporated in 1945 and is based in Buenos Aires, Argentina.
Earnings Per Share
As for profitability, Pampa Energia S.A. Pampa Energia S.A. has a trailing twelve months EPS of $5.5.
PE Ratio
Pampa Energia S.A. Pampa Energia S.A. has a trailing twelve months price to earnings ratio of 8.56. Meaning, the purchaser of the share is investing $8.56 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.12%.
Yearly Top and Bottom Value
Pampa Energia S.A. Pampa Energia S.A.’s stock is valued at $47.09 at 16:22 EST, under its 52-week high of $52.17 and way higher than its 52-week low of $32.91.
Revenue Growth
Year-on-year quarterly revenue growth grew by 127.1%, now sitting on 513.73B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 55.9% and a negative 53.9%, respectively.
Volume
Today’s last reported volume for Pampa Energia S.A. Pampa Energia S.A. is 250911 which is 25.73% below its average volume of 337880.
8. Novartis AG (NVS)
5.6% sales growth and 19.83% return on equity
Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
Earnings Per Share
As for profitability, Novartis AG has a trailing twelve months EPS of $4.1.
PE Ratio
Novartis AG has a trailing twelve months price to earnings ratio of 22.81. Meaning, the purchaser of the share is investing $22.81 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.83%.
Yearly Top and Bottom Value
Novartis AG’s stock is valued at $93.52 at 16:22 EST, way under its 52-week high of $108.78 and higher than its 52-week low of $92.19.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 7, 2024, the estimated forward annual dividend rate is 3.78 and the estimated forward annual dividend yield is 3.76%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 1.1% and 4.4%, respectively.
